To say this has been a big year for Summit Therapeutics (NASDAQ: SMMT) would be a huge understatement. The stock has risen ...

Bob Duggan, chairman and co-CEO of Summit Therapeutics Inc. (NASDAQ:SMMT), is capitalizing on a remarkable 689% stock surge ...

We recently compiled a list of the 10 Best QQQ Stocks to Buy According to Analysts. In this article, we are going to take a ...

The company provided clear evidence that it has plenty of resources to continue developing a potential blockbuster drug.

Summit Therapeutics is a biopharmaceutical company developing oncology drugs to treat various cancers. The company has not yet had any sales of its products. Its first potential drug, ivonescimab ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

However, one company wants to challenge Merck's crown jewel: Summit Therapeutics (NASDAQ: SMMT). This California-based biotech is developing a cancer medicine that has produced excellent clinical ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...